ArticleInternational journal of molecular sciences2024

T-Cell Dynamics Predicts Prognosis of Patients with Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab.

Hye Won Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.